1301 related articles for article (PubMed ID: 26821965)
1. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
2. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
Tarr T; Papp G; Nagy N; Cserép E; Zeher M
Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
4. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
[TBL] [Abstract][Full Text] [Related]
6. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
7. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Martinez-Berriotxoa A; Ugalde J; Aguirre C
Lupus; 2004; 13(12):900-5. PubMed ID: 15645743
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
[TBL] [Abstract][Full Text] [Related]
10. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
Aljohani R; Gladman DD; Su J; Urowitz MB
Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
[TBL] [Abstract][Full Text] [Related]
11. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
Taraborelli M; Leuenberger L; Lazzaroni MG; Martinazzi N; Zhang W; Franceschini F; Salmon J; Tincani A; Erkan D
Lupus; 2016 Oct; 25(12):1365-8. PubMed ID: 26945023
[TBL] [Abstract][Full Text] [Related]
12. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
Ceccarelli F; Pirone C; Mina C; Mascolo A; Perricone C; Massaro L; Spinelli FR; Alessandri C; Valesini G; Conti F
PLoS One; 2019; 14(11):e0224437. PubMed ID: 31682630
[TBL] [Abstract][Full Text] [Related]
13. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
15. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
[TBL] [Abstract][Full Text] [Related]
16. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
17. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage.
Brunner HI; Jones OY; Lovell DJ; Johnson AM; Alexander P; Klein-Gitelman MS
Lupus; 2003; 12(8):600-6. PubMed ID: 12945718
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
Legge A; Kirkland S; Rockwood K; Andreou P; Bae SC; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin PR; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcón GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askanase A; Hanly JG
Arthritis Rheumatol; 2020 Apr; 72(4):658-666. PubMed ID: 31631584
[TBL] [Abstract][Full Text] [Related]
19. The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts.
Frodlund M; Reid S; Wetterö J; Dahlström Ö; Sjöwall C; Leonard D
Lupus; 2019 Sep; 28(10):1261-1272. PubMed ID: 31296137
[TBL] [Abstract][Full Text] [Related]
20. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
Joo YB; Bae SC
Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]